Estabrook Capital Management
Source: SEC Form 13F · as of Mar 2026Estabrook Capital Management holds 29 biotech & pharma companies tracked by BioSniper, totaling $64.4M in value as of Mar 2026 (SEC Form 13F).
Companies held
29
Total value held
$64.4M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 89,857 | $22.0M |
| MRKMerck & Co., Inc. | 98,244 | $11.8M |
| PFEPFIZER INC | 329,763 | $9.3M |
| AMGNAMGEN INC | 18,847 | $6.6M |
| LLYELI LILLY & Co | 3,808 | $3.5M |
| ABBVAbbVie Inc. | 12,721 | $2.8M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 9,308 | $2.5M |
| GEHCGE HealthCare Technologies Inc. | 22,934 | $1.6M |
| VTRSViatris Inc | 95,322 | $1.3M |
| ABTABBOTT LABORATORIES | 8,664 | $890K |
| BMYBRISTOL MYERS SQUIBB CO | 9,563 | $580K |
| BIIBBIOGEN INC. | 2,000 | $367K |
| ZBHZimmer Biomet Holdings Inc. | 2,670 | $241K |
| REGNREGENERON PHARMACEUTICALS, INC. | 250 | $193K |
| GILDGILEAD SCIENCES, INC. | 1,216 | $169K |
| DVADaVita Inc. | 650 | $100K |
| QGENQIAGEN N.V. | 2,101 | $84K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 1,443 | $80K |
| CORCencora Inc. | 180 | $57K |
| AZNASTRAZENECA PLC | 237 | $47K |
| BNTXBioNTech SE | 500 | $44K |
| PMPhilip Morris International Inc | 192 | $32K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 69 | $31K |
| SNYSanofi | 562 | $27K |
| DGXQuest Diagnostics Incorporated | 94 | $18K |
| PGNYProgyny Inc. | 1,000 | $17K |
| ZTSZoetis Inc. | 118 | $14K |
| MCKMcKesson Corporation | 13 | $11K |
| OGNOrganon & Co. | 74 | $443 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.